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ORIGINAL RESEARCH
Sex Differences in Trends and In- Hospital 
Outcomes Among Patients With Critical 
Limb Ischemia: A Nationwide Analysis
Ayman Elbadawi , MD; Kirolos Barssoum, MD; Michael Megaly, MD; Devesh Rai , MD; Ahmed Elsherbeeny, MD; 
Hend Mansoor, PhD, PharmD; Mehdi H. Shishehbor , DO, MPH, PhD; Ahmed Abdel- Latif, MD;  
Martha Gulati , MD, MS; Islam Y. Elgendy , MD
BACKGROUND: Critical limb ischemia (CLI) represents the most severe form of peripheral artery disease and is associated with 
significant mortality and morbidity. Contemporary data comparing the sex differences in trends, revascularization strategies, 
and in- hospital outcomes among patients with CLI are scarce.
METHODS AND RESULTS: Using the National Inpatient Sample database years 2002 to 2015, we identified hospitalizations for 
CLI. Temporal trends for hospitalizations for CLI were evaluated. The differences in demographics, revascularization, and in- 
hospital outcomes between both sexes were compared. Among 2 400 778 CLI hospitalizations, 43.6% were women. Women 
were older and had a higher prevalence of obesity, hypertension, heart failure, and prior stroke. Women were also less likely to 
receive any revascularization (34.7% versus 35.4%, P<0.001), but the trends of revascularization have been increasing among 
both sexes. Revascularization was associated with lower in- hospital mortality among women (adjusted odds ratio [OR], 0.76; 
95% CI, 0.71– 0.81) and men (adjusted OR, 0.69; 95% CI, 0.65– 0.73). On multivariable analysis adjusting for patient- and 
hospital- related characteristics as well as revascularization, women had a higher incidence of in- hospital mortality, postopera-
tive hemorrhage, need for blood transfusion, postoperative infection, ischemic stroke, and discharge to facilities compared 
with men.
CONCLUSIONS: In this nationwide contemporary analysis of CLI hospitalizations, women were older and less likely to undergo 
revascularization. Women had a higher incidence of in- hospital mortality and bleeding complications compared with men. 
Sex- specific studies and interventions are needed to minimize these gaps among this high- risk population.
Key Words: critical limb ischemia ■ mortality ■ revascularization ■ sex ■ women
Lower extremity peripheral artery disease (PAD) affects millions of patients worldwide and carries significant morbidity and mortality.1 Studies sug-
gest that the prevalence of PAD is comparable among 
women and men,1 yet women are less frequently diag-
nosed and treated.1,2 Importantly, women have been 
underrepresented in clinical registries and trials of 
PAD.3– 6 This has led to a Call to Action by the American 
Heart Association recommending further sex- specific 
studies related to PAD.3
Critical limb ischemia (CLI) represents the most se-
vere form of PAD and is associated with considerable 
morbidity including limb loss, impaired quality of life, and 
mortality if not adequately managed.7 Studies suggest 
that women are more likely to present with advanced 
and multivessel PAD.8,9 Few studies have explored the 
sex- specific differences in presentation, revasculariza-
tion, and outcomes among patients with PAD.6,8,10– 12 
However, studies examining the sex- specific differ-
ences among patients with CLI have focused mainly 
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on outcomes after surgical intervention.13,14 With the 
advancements in endovascular techniques, the use of 
percutaneous revascularization has increased expo-
nentially for appropriate patients with CLI.15 To better 
address these knowledge gaps, we aimed to investi-
gate the trends and revascularization strategies, and 
to compare in- hospital outcomes among women and 
men with CLI using a large nationally representative 
database.
METHODS
Data that support the findings of this study are avail-
able from the corresponding author upon reasonable 
request.
Data Source
Data for this investigation were obtained from the 
National Inpatient Sample (NIS) database for January 
2002 through September 2015. The NIS is part of the 
Healthcare Cost and Utilization Project, sponsored by 
the Agency for Healthcare Research and Quality.16 The 
NIS is the largest inpatient- care database in the United 
States. The NIS contains discharge data from a ≈20% 
stratified sample of US hospitals through 2012. Since 
2012, the NIS represents a sample of 20% discharges 
from all hospitals.16 The NIS provides a weight vari-
able for establishing an estimate of national statistics. 
Because the NIS is a public database containing dei-
dentified information, this study was exempt from insti-
tutional review board approval.
Study Population
Hospitalizations for adults aged ≥18 years with primary 
International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD- 9- CM) diagnostic codes for 
CLI were identified (Table  S1).17,18 Using ICD- 9- CM 
procedure codes, we identified hospitalizations receiv-
ing endovascular revascularization (peripheral balloon 
angioplasty, atherectomy, or stent placement), surgi-
cal revascularization, and combined endovascular/
surgical revascularization (ie, hybrid revascularization) 
(Table S1).17,18 Cases with missing data on sex indicator 
or any of the study outcomes were excluded.
Patient and Hospital Characteristics
Baseline characteristics included patient demo-
graphics, relevant comorbidities (eg, hypertension, 
hyperlipidemia, diabetes, coronary artery disease, 
cardiomyopathy, heart failure, valvular heart disease, 
obesity, smoking history, chronic kidney disease, prior 
myocardial infarction, previous percutaneous coronary 
intervention, previous coronary artery bypass grafting, 
and prior stroke) were identified using corresponding 
ICD- 9- CM codes. A list of ICD- 9- CM codes used to 
identify the comorbidities and therapies is summarized 
in Table  S1. Hospital- related characteristics included 
bed size (small, medium, and large), location (urban 
versus rural), hospital region (Northeast, Midwest, 
South, and West), and teaching status.
Outcome Measures
The temporal trends in hospitalizations and revascu-
larization modalities in women versus men present-
ing with CLI were reported. The main study outcome 
was in- hospital mortality. Other secondary outcomes 
included amputation- free survival (defined as freedom 
from death or major amputation during the hospitaliza-
tion), major amputation, minor amputation, postopera-
tive infection, postoperative hemorrhage, acute stroke, 
and acute kidney injury (AKI). Procedures and inpatient 
outcomes were abstracted and reported using ICD- 
9- CM Clinical Classifications Software codes and 
Elixhauser comorbidities as reported by the Healthcare 
Cost and Utilization Project (Table S1).
Statistical Analysis
Discharge (trend) weights were used to compute na-
tional estimates. As per Healthcare Cost and Utilization 
CLINICAL PERSPECTIVE
What Is New?
• In this nationwide analysis of critical limb is-
chemia hospitalizations, women were older and 
less likely to undergo revascularization.
• Women with critical limb ischemia had a higher 
incidence of adjusted in- hospital mortality, 
bleeding complications, and discharge to facili-
ties compared with men.
• Endovascular revascularization was associated 
with lower adjusted in- hospital mortality among 
both women and men compared with surgical 
revascularization.
What Are the Clinical Implications?
• Sex- specific studies and interventions are 
needed to minimize these gaps among patients 
with critical limb ischemia.
Nonstandard Abbreviations and Acronyms
AKI acute kidney injury
CLI critical limb ischemia
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Project regulations, all analyses were conducted using 
the complex sample feature of SPSS software (IBM, 
Armonk, NY), which accounts for discharge weights, 
hospital clustering, and stratification across the NIS 
database.19 Categorical variables were compared 
using the χ2 test and reported as numbers and per-
centages. Continuous variables were compared using 
the Student t test or Mann- Whitney U test depend-
ing on the distribution curve and were reported as 
mean±standard deviation or median and interquartile 
range depending on the distribution curve. Trend anal-
yses were performed using linear regression analysis 
or curvilinear regression analysis depending on the 
shape of the curve.20
Multivariable regression analysis was conducted 
to adjust for in- hospital outcomes for CLI in women 
versus men. The model included the following 25 vari-
ables: age, race, diabetes, hypertension, obesity, his-
tory of heart failure, chronic lung disease, pulmonary 
circulation disorders, chronic liver disease, chronic 
kidney disease, chronic anemia, coagulopathy, hy-
pothyroidism, history of smoking, coronary artery 
disease, prior myocardial infarction, history of implant-
able cardiac defibrillator, history of cardiac pacemaker, 
prior stroke, prior percutaneous coronary intervention, 
prior previous coronary artery bypass grafting, hospi-
tal bed size, hospital region, hospital teaching status, 
and the revascularization modality. In hospitalizations 
with missing covariates, multivariable regression anal-
yses were performed on complete cases. All vari-
ables were forced into the multivariable model using 
the enter method. A secondary propensity- score 
matching analysis was conducted to compare the 
in- hospital outcomes between women and men. The 
matching was performed using the MatchIt R package 
(R software; R Foundation for Statistical Computing, 
Vienna, Austria). Each case was matched to a control 
that was closest in terms of the calculated propensity 
score, using the nearest neighbor technique, with a 
caliper width of 0.2. The propensity score was cal-
culated from the same patient- and hospital- related 
variables used in the regression models. Subgroup 
analyses according to age (ie, <50 versus ≥50 years) 
and hospital location (ie, urban versus rural) were also 
performed to compare in- hospital mortality and post-
operative hemorrhage.
To compare the outcomes of endovascular versus 
surgical revascularization, a propensity- score match-
ing model was used to reduce the risk of selection 
bias. The matching was performed using MatchIt R 
package. Each case was matched to a control that 
was closest in terms of calculated propensity score, 
using the nearest neighbor technique, with a caliper 
width of 0.2. The propensity score was calculated 
from the same patient- and hospital- related variables 
in the regression models, except for revascularization 
modality (Table  S2). Associations were considered 
significant if the P value was ≤0.05. We used the 




Between January 2002 and September 2015, there 
were 2 401 110 hospitalizations with a primary diagno-
sis of CLI. After excluding cases with missing data on 
sex indicator (n=15) or missing study outcomes (n=317), 
the final analysis included 2 400 778 hospitalizations; 
1 047 406 (43.6%) were women. Women with CLI were 
older and less likely White or Hispanic. Women had a 
higher prevalence of obesity, hypertension, heart fail-
ure, and prior stroke. Women had a lower prevalence 
of smoking, diabetes, coronary artery disease, prior 
myocardial infarction, prior percutaneous coronary in-
tervention, and prior coronary artery bypass grafting. 
Table 1 summarizes the baseline patient- and hospital- 
related characteristics.
Women were less likely to receive any revasculariza-
tion during the index admission (34.7% versus 35.4%, 
P<0.001). Compared with nonrevascularized patients, 
women undergoing any revascularization had a lower 
incidence of in- hospital mortality (2.6% versus 4.2%; 
adjusted odds ratio [OR], 0.76; 95% CI, 0.71– 0.81; 
P<0.001) as well as men (2.2% versus 3.8%; adjusted 
OR, 0.69; 95% CI, 0.65– 0.73; P<0.001). Women were 
more likely to receive endovascular revascularization 
(15.9% versus 14.7%, P<0.001) and less likely to re-
ceive surgical revascularization (12.5% versus 13.7%, 
P<0.001) compared with men.
Trends in Hospitalizations for CLI 
Hospitalizations and Revascularization 
Strategies
During the study period, the rates of CLI hospitaliza-
tions did not change among women (82 706 in 2002 
versus 75  193 in 2015, Ptrend=0.10) but increased 
among men (95 456 in 2002 versus 111 573 in 2015, 
Ptrend<0.001) (Figure 1). There was a decrease in the 
rates of in- hospital mortality among women (5.2% in 
2002 versus 2.9% in 2015, Ptrend<0.001) and men (4.5% 
in 2002 versus 2.7% in 2015, Ptrend<0.001) (Figure 2).
There has been an increase in total revascularization 
regardless of strategy among women (28.8% in 2002 
versus 36.7% in 2015, Ptrend<0.001) and men (29.8% 
in 2002 versus 38.1% in 2015, Ptrend<0.001). Among 
women, both endovascular revascularization (5.6% in 
2002 versus 20.0% in 2015, Ptrend<0.001) and hybrid 
revascularization (2.3% in 2002 versus 8.9% in 2015, 
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decreased (20.9% in 2002 versus 7.7% in 2015, 
Ptrend<0.001). A similar pattern was observed among 
men with an observed increase in both endovascular 
revascularization (4.7% in 2002 versus 19.1% in 2015, 
Ptrend<0.001) and hybrid revascularization (2.5% in 2002 
versus 9.5% in 2015, Ptrend<0.001), but a reduction in 
surgical revascularization (22.6% in 2002 versus 9.5% 
in 2015, Ptrend<0.001) (Figure 1).
In- Hospital Outcomes
In the unadjusted analysis, women had a higher 
incidence of in- hospital mortality, postoperative 
Table 1. Baseline Patient- and Hospital- Related Characteristics Among Women Versus Men With Critical Limb Ischemia
Women, n=1 047 406, n (%) Men, n=1 353 704, n (%) P value
Age, y, mean±SD 72.1±13.6 68.4±12.7 <0.001
Race/ethnicity
White 568 880 (64.3) 787 021 (68.3) <0.001
Black 192 047 (21.7) 193 687 (16.8)
Hispanic 84 499 (9.6) 120 872 (10.5)
Asian/Pacific Islander 12 763 (1.4) 15 296 (1.3)
Other races* 6034 (0.7) 7460 (0.6)
Smoking 131 176 (12.5) 236 664 (17.5) <0.001
Obesity 113 734 (11.0) 113 360 (8.4) <0.001
Hypertension 745 948 (71.9) 934 893 (69.7) <0.001
Hypothyroidism 152 436 (14.7) 83 464 (6.2) <0.001
Chronic kidney disease 288 973 (27.80) 428 639 (31.90) <0.001
Chronic liver disease 14 806 (1.4) 33 803 (2.5) <0.001
Diabetes 505 219 (48.7) 716 988 (53.4) <0.001
Anemia 300 542 (29.0) 351 124 (26.2) <0.001
Heart failure 209 416 (20.2) 258 830 (19.3) <0.001
Chronic pulmonary disease 240 267 (23.20) 311 715 (23.20) 0.57
Valvular disease 63 038 (6.1) 67 849 (5.1) <0.001
Coronary artery disease 394 495 (37.7) 621 865 (45.9) <0.001
Prior myocardial infarction 82 195 (7.8) 137 245 (10.1) <0.001
Prior coronary artery bypass surgery 92 077 (8.8) 203 383 (15.0) <0.001
Prior implantable cardioverter defibrillator 9691 (0.9) 33 573 (2.5) <0.001
Prior cardiac pacemaker 36 750 (3.5) 51 878 (3.8) <0.001
Prior percutaneous coronary intervention 54 461 (5.2) 88 076 (6.5) <0.001
Prior stroke 53 207 (5.1) 65 248 (4.8) <0.001
Coagulopathy 35 319 (3.4) 53 133 (4.0) <0.001
Pulmonary circulation disease 28 643 (2.80) 27 175 (2.00) <0.001
Hospital- related characteristics
Hospital bed size
Small sized 121 579 (11.6) 153 550 (11.4) <0.001
Medium sized 268 472 (25.7) 339 944 (25.2)
Large sized 654 481 (62.7) 856 433 (63.4)
Hospital region
Northeast 218 917 (20.9) 284 809 (21.0) <0.001
Midwest or North Central 243 442 (23.2) 313 211 (23.1)
South 417 892 (39.9) 529 978 (39.2)
West 167 157 (16.0) 225 372 (16.7)
Hospital teaching status
Rural 107 021 (10.2) 131 045 (9.7) <0.001
Urban nonteaching 425 875 (40.8) 544 454 (40.3)
Urban teaching 511 636 (49.0) 674 428 (50.0)
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hemorrhage, need for blood transfusion, postoperative 
infection, ischemic stroke, and discharge to facilities 
compared with men. Women were less likely to un-
dergo major or minor amputations and had a lower inci-
dence of AKI but a higher incidence of amputation- free 
survival (Table 2). These findings remained consistent 
in the multivariable logistic regression model adjusting 
for the patient- and hospital- related characteristics as 
well as the revascularization strategy. The secondary 
analysis using the propensity- score matching model 
also demonstrated similar findings (Table S3). Women 
had higher rates of in- hospital mortality across the vari-
ous racial and ethnic groups (Table S4).
On subgroup analysis according to age, women aged 
≥50 years had higher adjusted in- hospital mortality com-
pared with men (adjusted OR, 1.08; 95% CI, 1.04– 1.12), 
but there was no difference in the adjusted in- hospital 
mortality rates between women and men aged <50 years 
(adjusted OR, 1.07; 95% CI, 0.87– 1.32). In addition, 
women had higher adjusted postoperative hemorrhage 
in the subgroup of those aged ≥50 years (adjusted OR, 
1.19; 95% CI, 1.16– 1.22) and <50  years (adjusted OR, 
1.23; 95% CI, 1.10– 1.37) compared with men (Figure S1). 
Women aged ≥50 years had higher adjusted in- hospital 
mortality rates (adjusted OR, 2.55; 95% CI, 2.12– 3.06) 
and postoperative hemorrhage (adjusted OR, 1.15; 95% 
CI 1.03– 1.28) compared with women aged <50 years.
Among admissions in urban areas, adjusted in- 
hospital mortality (adjusted OR, 1.08; 95% CI, 1.04– 
1.12) and postoperative hemorrhage (adjusted OR, 
1.19; 95% CI, 1.16– 1.22) was higher in women versus 
men. However, there was no significant difference in in- 
hospital mortality between women versus men in rural 
areas (adjusted OR, 0.97; 95% CI, 0.84– 1.10) (Figure S1).
Outcomes of Endovascular Versus 
Surgical Revascularization
Among women with CLI who underwent either endo-
vascular or surgical intervention (n=297  658), 128  604 
Figure 1. Summary for the findings of the study.
Temporal trend in hospitalizations and revascularization modalities for critical limb ischemia (CLI) among women and men. NIS, 
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who had endovascular revascularization were matched 
with 127  353 who had surgical revascularization. The 
absolute standardized differences for the patient- and 
hospital- related characteristics were <10% in both groups 
(Figure S2A). Compared with surgical revascularization, 
endovascular revascularization was associated with a 
lower incidence of in- hospital mortality, minor amputation, 
postoperative hemorrhage, need for blood transfusion, 
postoperative infection, and discharge to facilities, but a 
higher incidence of major amputation and AKI (Table 3). In 
addition, endovascular revascularization was associated 
with a shorter length of stay (5 days [interquartile range, 
2– 10 days] versus 7 days [interquartile range, 4– 13 days], 
P<0.001).
Similarly, propensity analysis matched 162 857 male 
patients with CLI undergoing endovascular revasculariza-
tion and 161 498 undergoing surgical revascularization. 
There were minimal differences (ie, <10%) in the abso-
lute standardized differences after matching (Figure 2B). 
Endovascular revascularization was associated with a 
lower incidence of in- hospital mortality, postoperative 
hemorrhage, need for blood transfusion, postoperative 
infection, length of stay, and discharge to facilities, but a 
higher incidence of major amputation and AKI (Table 4).
Figure 2. Temporal trends of in- hospital mortality for hospitalization with critical limb ischemia 
(CLI) among women and men.
 




odds ratio 95% CI
Adjusted odds 
ratio* 95% CI P valueWomen Men
Mortality 3.7 3.2 1.13 1.10– 1.17 1.07 1.03– 1.11 <0.001
Amputation- free survival 81.9 81.2 1.05 1.03– 1.06 1.10 1.10– 1.12 <0.001
Major amputation 15.3 16.3 0.92 0.91– 0.94 0.88 0.86– 0.89 <0.001
Minor amputation 9.8 14.7 0.63 0.62– 0.65 0.66 0.65– 0.67 <0.001
Postoperative infection 2.2 2.0 1.10 1.06– 1.15 1.20 1.14– 1.25 <0.001
Postoperative hemorrhage 8.0 7.0 1.16 1.13– 1.18 1.19 1.16– 1.22 <0.001
Blood transfusion 18.1 15.6 1.19 1.17– 1.21 1.17 1.15– 1.19 <0.001
Acute myocardial infarction 2.9 3.1 0.95 0.92– 0.99 1.02 0.98– 1.06 0.24
Ischemic stroke 0.9 0.7 1.27 1.19– 1.35 1.20 1.12– 1.29 <0.001
Acute kidney injury 11.2 12.5 0.88 0.87– 0.90 0.86 0.84– 0.88 <0.001
Facility discharge 40.2 35.2 1.24 1.22– 1.25 1.04 1.03– 1.06 <0.001
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DISCUSSION
In this nationally representative observational analysis 
of ≈2.4 million hospitalizations with CLI, we found that 
women with CLI were older and had a higher preva-
lence of certain cardiovascular risk factors such as 
obesity and hypertension compared with men. The 
rates of hospitalizations for CLI did not change among 
women but increased in men. Women with CLI were 
less likely to undergo any revascularization compared 
with men. Furthermore, women with CLI had a higher 
incidence of adjusted in- hospital mortality, bleeding 
complications, and discharge to facilities compared 
with men. Endovascular revascularization was associ-
ated with lower adjusted in- hospital mortality among 
women and men, compared with surgical revasculari-
zation. These findings suggest that although the rates 
of CLI might be higher among men, the prevalence 
of cardiovascular risk factors and revascularization- 
related complications are likely higher among women, 
and women with CLI are less likely to receive any 
revascularization.
Prior studies exploring the sex differences among 
patients with PAD showed that women are older 
and have a higher prevalence of hypertension and 
obesity10,11; however, these studies included only 
a small proportion of patients with CLI. Our findings 
extend this knowledge to a large cohort and confirm 
the trends seen in earlier studies. A prior analysis has 
shown that the rates of CLI hospitalizations remained 
constant from 2003 to 2011 in the United States.17 In 
this study, we showed that the rates of CLI hospitaliza-
tions did not change among women but have modestly 
increased among men. This could be attributed to the 
hesitancy for hospital admittance in patients with CLI 
who are women or less serious presentation among 
women, requiring hospitalization less often. Similar to 
prior CLI studies that had a predominant male repre-
sentation,21,22 we found that the rates of revasculariza-
tion were overall low (<35%), but lower among women 
compared with men. This is concerning given that re-
vascularization has been associated with lower mor-
tality, as demonstrated in our analysis, and improved 
quality of life in this high- risk population.7,21 This fur-
ther highlights the sex- related gaps in evidence- based 
therapies that has been previously demonstrated in 
other cardiovascular diseases.23,24 A previous anal-
ysis of the reduction of atherothrombosis for contin-
ued health (REACH) registry has shown that risk factor 
control is suboptimal among women compared with 




Odds ratio 95% CI P valueEndovascular Surgical
Mortality 2.3 2.7 0.84 0.75– 0.95 0.004
Major amputation 6.5 5.6 1.17 1.09– 1.26 <0.001
Minor amputation 11.7 12.5 0.93 0.88– 0.98 0.01
Postoperative infection 1.2 3.2 0.37 0.33– 0.43 <0.001
Postoperative hemorrhage 10.1 16.1 0.58 0.55– 0.62 <0.001
Blood transfusion 14.0 29.4 0.39 0.37– 0.41 <0.001
Acute kidney injury 10.1 8.0 1.29 1.21– 1.37 <0.001
Discharge to facility 29.6 39.7 0.64 0.61– 0.67 <0.001




Odds ratio 95% CI P valueEndovascular Surgical
Mortality 1.9 2.3 0.83 0.75– 0.92 0.001
Major amputation 7.6 5.9 1.32 1.23– 1.40 <0.001
Minor amputation 18.2 17.8 1.02 0.98– 1.07 0.28
Postoperative infection 1.2 2.7 0.43 0.38– 0.48 <0.001
Postoperative hemorrhage 7.5 12.9 0.55 0.52– 0.58 <0.001
Blood transfusion 11.1 22.4 0.43 0.41– 0.46 <0.001
Acute kidney injury 11.5 8.9 1.34 1.27– 1.41 <0.001




 http://ahajournals.org by on N
ovem
ber 17, 2021
J Am Heart Assoc. 2021;10:e022043. DOI: 10.1161/JAHA.121.022043 8
Elbadawi et al Sex Differences in CLI
men with PAD.25 Reassuringly, we found that the rates 
of in- hospital mortality are decreasing among women 
and men. This might be related to the rise in the rates 
of revascularization procedures, as well as the im-
provements in secondary preventative strategies in-
cluding smoking cessation, statin therapy, and cardiac 
rehabilitation.15,21,26
Evidence on sex- specific differences in the out-
comes of patients with PAD have been controversial 
and mostly noncontemporary.27– 29 A sex- specific anal-
ysis of the examining use of ticagrelor in peripheral 
artery disease (EUCLID) trial found that women had 
a lower risk of all- cause mortality, but similar risk of 
limb adverse events at a mean of 30 months.10 Among 
studies focusing on patients with PAD who under-
went endovascular revascularization, women were 
found to have higher rates of bleeding and vascular 
complications.8 However, the rate of in- hospital mor-
tality was similar in one study,8 and long- term mortality 
was higher among women in another study.11 Studies 
evaluating sex- specific differences among patients 
with CLI have been limited.14,30 One study comparing 
the outcomes after surgical interventions showed that 
women had lower patency rates after bypass surgery.14 
Another single- center study of 219 patients (44% 
women) demonstrated that women had higher rates 
of the composite of mortality, myocardial infarction, or 
stroke, and lower rates of postprocedural patency for 
infrainguinal endovascular interventions.30 In our study, 
which focused on patients with CLI, we found that 
women had higher rates of in- hospital mortality, bleed-
ing complications, but a lower rate of amputations and 
AKI. Several factors could contribute to these findings, 
such as the smaller blood vessel diameter along with 
the higher prevalence of more complex and multilevel 
disease among women.6,30 Importantly, we found that 
the higher rates of mortality and bleeding complica-
tions among women were mainly observed in those 
aged ≥50  years (ie, likely postmenopausal), support-
ing the hypothesis of the protective role for estrogen 
against potential limb ischemia in women.31
Randomized trial data comparing endovascular 
therapy versus surgical interventions are scarce.32 
The bypass versus angioplasty in severe ischaemia 
of the leg (BASIL) trial demonstrated that an endovas-
cular approach was comparable to surgery for CLI.32 
However, endovascular techniques have evolved since 
the BASIL trial. Furthermore, sex- specific differences 
in the outcomes of both strategies have not been as-
sessed in the BASIL trial.32 In the propensity- matched 
analysis, we showed that endovascular revasculariza-
tion was associated with lower in- hospital mortality in 
both women and men. These findings should only be 
considered as hypothesis generating given the poten-
tial for selection bias. The ongoing best endovascular 
versus best surgical therapy for patients with critical 
limb ischemia (BEST- CLI) trial is comparing the out-
comes of endovascular and surgical revascularization 
approaches among patients with CLI eligible for both 
modalities.33 Hopefully, the BEST- CLI trial will recruit 
a representative sample of women to evaluate sex 
differences in outcomes with both revascularization 
strategies.
The strengths of this analysis are driven from the large 
sample size with national representation, in a more con-
temporary population than previous studies. However, 
the findings of this analysis should be interpreted in the 
context of certain limitations. First, this is an observa-
tional nonrandomized study. Although we adjusted for 
potential confounders and conducted several statistical 
models, the risk of unmeasured confounding could not 
be excluded. Second, the NIS lacks data on outcomes 
beyond the index hospitalization. Specifically, for those 
with CLI that was untreated, there is no information on 
their long- term outcomes, and those untreated were 
more likely to be women. Third, the NIS is an admin-
istrative database that relies on ICD- 9- CM codes, and 
thus is subject to miscoding and undercoding. Fourth, 
we did not have access to important clinical data, be-
cause imaging, extent of the disease, and medical ther-
apies administrated during the hospitalization were not 
available. Fifth, data on menopausal state and estrogen 
replacement therapy were not available in this data set, 
so a subgroup analysis for age <50 versus ≥50 years 
was performed, which is the mean age of menopause 
in the United States for the past 2 decades.34 Sixth, 
this analysis was not designed to directly compare the 
outcomes of different revascularization strategies (ie, 
endovascular or surgical) between women and men. 
Finally, the clinical reasoning for choosing one revascu-
larization technique versus the other could not be de-
termined. We attempted to mitigate this by performing 
a propensity- matched model.
CONCLUSIONS
In this nationwide contemporary analysis of CLI hos-
pitalizations, we demonstrated that women with CLI 
were older and had a higher prevalence of certain car-
diovascular risk factors such as obesity and hyperten-
sion compared with men. The rates of hospitalizations 
for CLI did not change among women but increased in 
men. Women with CLI were less likely to undergo any 
revascularization compared with men, but the trends 
of revascularization have been increasing among both 
sexes, particularly endovascular revascularization. 
Women with CLI had a higher incidence of adjusted 
in- hospital mortality, bleeding complications, and dis-
charge to facilities compared with men. Endovascular 
revascularization was associated with lower adjusted 
in- hospital mortality among both women and men, 
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interpretation of this finding is limited by the observa-
tional nature of the study.
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Table S1. International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9- CM) codes 
used to identify the baseline comorbidities, procedures, and in-hospital outcomes. 
Critical limb ischemia 
Atherosclerosis of native arteries of extremities 
-with rest pain 440.22 
-with gangrene 440.24 
-with ulceration 440.23, 707.9 
Critical limb ischemia if following code is present along 
with a primary diagnosis code for PAD* 
Gangrene 785.4 
Ulcer of lower limb (includes trophic ulcer) 707.10, 707.11, 707.12, 707.13, 707.14, 
707.15, 707.19 
Acute osteomyelitis of pelvic region and thigh 730.05 
Acute osteomyelitis of lower extremity 730.06 
Acute osteomyelitis of ankle and foot 730.07 
Chronic osteomyelitis of pelvic region and thigh 730.15 
Chronic osteomyelitis of lower extremity 730.16 
Chronic osteomyelitis of ankle and foot 730.17 
Cellulitis of lower extremity except foot 682.6 
Cellulitis of foot except toes 682.7 
Cellulitis of toes 681.1 
*Primary PAD diagnosis
Atherosclerosis of native arteries of extremities with 
intermittent claudication, rest pain, ulceration, 
gangrene or unspecified symptoms. 
440.2 (440.20-440.24, 440.29) 
Atherosclerosis of bypass graft of extremities 440.3 (440.0-440.32) 
Atherosclerosis- generalized or unspecified 440.9 
Atherosclerosis of Aorta 440.0 
Diabetes mellitus with peripheral circulatory 
disorders 
249.70, 249.71, 250.70-250.73 
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Peripheral vascular disease, unspecified 443.9 
Buerger’s disease 443.1 
Arterial embolism/ thrombosis of lower extremity 
or iliofemoral artery 
444.22, 444.81 
Surgical Revascularization 
Aorto-iliac femoral bypass 39.25 
Peripheral bypass 39.29 
Incision of lower limb arteries 38.08 
Endarterectomy of abdominal arteries 38.16 
Endarterectomy of lower limb arteries 38.18 
Resection of vessel with anastomosis 38.38 
Resection of vessel with replacement 38.48 
Endovascular revascularization 
Angioplasty or atherectomy of non-coronary vessel 39.50 
Insertion of non-drug-eluting, non-coronary artery 
stent 
39.90 
Insertion of drug eluting peripheral vessel stent 00.55 
Major amputation of lower extremity 
Lower limb amputation 84.10 
Disarticulation of ankle 84.13 
Amputation of ankle through malleoli of tibia and 
fibula 
84.14 
Other amputation-below knee 84.15 
Disarticulation of knee 84.16 
Amputation above knee 84.17 
Revision of amputation stump 84.3 
Minor amputation of lower extremity 
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Trans metatarsal amputation 84.12 
Vascular procedures, non-specific, only used in 
conjunction with lower extremity procedure codes 
Procedure on single vessel 00.40 
Procedure on two vessels 00.41 
Procedure on three vessels 00.42 
Procedure on ≥ 4 vessels 00.43 
Procedure on vessel bifurcation 00.44 
Insertion of one vascular stent 00.45 
Insertion of two vascular stents 00.46 
Insertion of three vascular stents 00.47 
Insertion of ≥ 4 vascular stents 00.48 
Non-ST-elevation myocardial infarction 410.7x 
ST-elevation myocardial infarction 410.1x, 410.2x, 410.3x, 410.4x, 410.5x, 
410.6x, 410.8x and 410.9x 
Prior myocardial infarction 412.0 
Previous percutaneous coronary intervention V45.82 
Previous coronary artery bypass grafting V45.81 
Previous CVA V12.54 
Carotid artery disease 433.10 
Cardiogenic shock 785.51 
Cardiac arrest CCS-107 
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Acute stroke CCS-100 
Respiratory complications 997.3, 997.31, 997.32, 997.39 
Permanent pacemaker 37.80 37.83 
Acute kidney injury 584 
Vascular complications 39.31, 39.41, 39.49, 39.52, 39.53, 
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Table S2. List of variables used in the propensity score matching analysis comparing the 
revascularization strategies. 
Age, race, diabetes mellitus, hypertension, obesity, history of heart failure, chronic 
lung disease, pulmonary circulation disorders, chronic liver disease, CKD, chronic 
anemia, coagulopathy, hypothyroidism, history of smoking, coronary artery 
disease, prior MI, history of implantable cardiac defibrillator, history of cardiac 
pacemaker, prior stroke, prior PCI, prior CABG, hospital bed-size, hospital region, 
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Table S3. In-hospital outcomes among women versus men with critical limb ischemia after propensity score matching 






Mortality 3.7% 3.4% 1.09 1.07-1.10 <0.001 
Amputation free survival  82.0% 81.1% 1.06 1.05-1.07 <0.001 
Major amputation 15.3% 16.4% 0.92 0.91.0.93 <0.001 
Minor amputation 10.0% 14.3% 0.67 0.66-0.67 <0.001 
Post-operative infection  2.3% 1.9% 1.17 1.15-1.20 <0.001 
Post-operative hemorrhage  8.1% 7.1% 1.16 1.15-1.18 <0.001 
Blood transfusion  18.3% 16.0% 1.17 1.17-1.18 <0.001 
Acute myocardial infarction 3.0% 3.0% 0.99 0.97-1.00 0.10 
Ischemic stroke  0.9% 0.7% 1.25 1.22-1.29 <0.001 
Acute kidney injury  11.3% 12.9% 0.86 0.85-0.87 <0.001 
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Table S4. Sex-related differences in in-hospital mortality across various racial groups.
Outcome Incidences % Odds ratio 95% confidence interval P-value
Women Men 
White 
Mortality 3.5% 3.3% 1.083 1.063 1.103 <0.001 
Black 
Mortality 3.8% 3.2% 1.191 1.151 1.233 <0.001 
Hispanic 
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Standardized differences before matching
(A) (B)
Figure S2.  Absolute standardized differences for the patient and hospital-related characteristics included in the propensity matched model comparing endovascular 
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